Axon Enterprise, Inc. Stock News

Axon Enterprise, Inc. (NASDAQ:AXON) President Luke Larson sold 733 shares of the stock in a transaction dated Wednesday, December 1st. The stock was sold at an average price of $162.90, for a total value of $119,405.70. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this []

Axon Enterprise, Inc. (NASDAQ:AXON) CRO Joshua Isner sold 276 shares of the businesss stock in a transaction that occurred on Wednesday, December 1st. The shares were sold at an average price of $162.89, for a total transaction of $44,957.64. The sale was disclosed in a legal filing with the SEC, which can be accessed through []

New Mexico Educational Retirement Board acquired a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) during the third quarter, HoldingsChannel reports. The fund acquired 13,200 shares of the biotechnology companys stock, valued at approximately $2,310,000. A number of other hedge funds also recently added to or reduced their stakes in the stock. Fifth Third []

Life without these companies' products will be hard to imagine.

Axon Enterprise, Inc. (NASDAQ:AXON) CEO Patrick W. Smith sold 4,535 shares of Axon Enterprise stock in a transaction on Friday, November 26th. The stock was sold at an average price of $180.07, for a total transaction of $816,617.45. The sale was disclosed in a document filed with the SEC, which can be accessed through this […]

Axon Enterprise, Inc. (NASDAQ:AXON) CEO Patrick W. Smith sold 39,291 shares of the businesss stock in a transaction dated Monday, November 29th. The stock was sold at an average price of $180.15, for a total transaction of $7,078,273.65. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Shares []

Juncture Wealth Strategies LLC lifted its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 6.1% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,890 shares of the biotechnology companys stock after purchasing an additional 282 shares during the period. Juncture []

We all know the power of a tweet from Elon Musk. Here are seven stocks to buy before he calls attention to them on social media.

During the last session, Axon Enterprise Inc. (NASDAQ:AXON)s traded shares were 0.42 million, with the beta value of the company hitting 0.37. At the end of the trading day, the stocks price was $179.86, reflecting an intraday gain of 3.16% or $5.51. The 52-week high for the AXON share is $212.37, that puts it down Should Axon Enterprise Inc. (NASDAQ: AXON) Revive After A -18.08% Drop From Highs? Read More »

Dublin, Nov. 25, 2021 (GLOBE NEWSWIRE) -- The "Global Wearable Camera Market (2021-2026) by Type, End-User, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com''s offering. The Global Wearable Camera Market is estimated to be USD 4.6 Bn in 2020 and is expected to reach USD 7.48 Bn by 2025, growing at a CAGR of 10.2%. Market Dynamics Increasing outdoor activities such as water sports, hiking, sky-diving, etc., coupled with rising tourism, is increasing the demand for wearable cameras. Like Facebook, Instagram, social media platforms have developed the scope of photography and video around the world. In addition, the rising live streaming trend is significantly increasing the market growth. The growing applications of wearable cameras in security and surveillance, healthcare, sports, and other sectors have witnessed robust impetus in the market. However, the high cost and privacy & ethical issues of wearable cameras are expected to hinder the market growth.

Marshall Wace North America L.P. acquired a new stake in Axon Enterprise, Inc. (NASDAQ:AXON) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 7,893 shares of the biotechnology companys stock, valued at approximately $1,395,000. Other large investors have also recently added to or reduced their []

Thrivent Financial for Lutherans bought a new position in Axon Enterprise, Inc. (NASDAQ:AXON) during the second quarter, HoldingsChannel.com reports. The fund bought 17,171 shares of the biotechnology companys stock, valued at approximately $3,036,000. Several other hedge funds and other institutional investors also recently added to or reduced their stakes in AXON. BlackRock Inc. purchased a []

Axon Enterprise, Inc. (NASDAQ:AXON) CEO Patrick W. Smith sold 329,952 shares of the stock in a transaction dated Tuesday, November 16th. The stock was sold at an average price of $186.25, for a total transaction of $61,453,560.00. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. []

William Blair restated their outperform rating on shares of Axon Enterprise (NASDAQ:AXON) in a report published on Tuesday, Zacks.com reports. Several other analysts also recently weighed in on AXON. Zacks Investment Research upgraded Axon Enterprise from a strong sell rating to a hold rating in a research note on Monday, October 11th. Raymond James upped []

Beese Fulmer Investment Management Inc. bought a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 3,568 shares of the biotechnology companys stock, valued at approximately $624,000. Several other institutional investors have also recently bought []